The FDA record for K260940 identifies ZimVie US Corp, LLC as the applicant for BellaTek Bars, with a decision date of September 21, 2026 and a substantially equivalent determination. The filing lists the device as a Class II endosseous dental implant abutment under regulation 21 CFR 872.3630 and product code NHA, reviewed by the Dental advisory committee. The same record gives a Palm Beach Gardens, Florida filing address and names Ana Leitão as contact. That address appears in a regulatory filing and is not treated here as a verified corporate headquarters. [1][2]

The K260940 filing and its scope

K260940 was received March 20, 2026 and decided September 21, 2026 with decision code SESE, described as Substantially Equivalent. The clearance type is recorded as Special, the third-party flag is No, and the statement or summary field indicates a Summary. The device is listed as BellaTek Bars, trade name BellaTek Bars, with the applicant recorded as ZimVie US Corp, LLC. [1][2]

The FDA determination letter restates the same regulatory identity: trade name BellaTek Bars, regulation number 21 CFR 872.3630, regulation name Endosseous Dental Implant Abutment, Class II, product code NHA. The letter is addressed to Ana Leitão, Regulatory Affairs Manager Global, at 4555 Riverside Dr., Palm Beach Gardens, Florida 33410. [2]

Predicate lineage and device description

The K260940 documentation references a primary predicate device, K241032, cleared for BellaTek Bars. The subject device is described as adding compatibilities with Terrats Medical SL multi-unit abutments that contain the same abutment-to-bar connection geometry as the abutments cleared in K241032. [2][7]

Materials and manufacturing are stated as identical for the subject and primary predicate device: bar material Ti-6Al-4V ELI per ASTM F136 or Grade 4 CP Titanium per ASTM F67, nylon pouch packaging, and non-sterile presentation. The K241032 record describes the predicate devices as provided non-sterile in the same manner. [2][7]

The K241032 documentation lists design limits for the bar and framework family, including platform seating diameters from 3.4 mm to 6.1 mm, two to ten total cylinders, bar spans between cylinders from 0 mm to 27 mm, bar height from 2.5 mm to 10 mm, bar width from 1.8 mm to 10 mm, distal extension from 0 mm to 10.7 mm, cylinder height from 0 mm to 10 mm, cylinder diameter from 3.4 mm to 10 mm, and maximum angulation between cylinders from 0° to 30°. [7]

Published product documentation

ZimVie’s BellaTek Bars and Frameworks page describes bars and frameworks for all indications and engineered to provide a precise, passive fit, and states the products are only available in the U.S.A and Canada. The page is published for dental professionals and links to a ZimVie Milling Portal and STL libraries. [4]

ZimVie’s Full Arch Product Catalog lists BellaTek Bars and Frameworks within a portfolio that also includes TSX Implants, T3 PRO Implants, the RealGUIDE Z3D Guided Surgery Kit, the Tapered Navigator Kit, Scan Bar, Smart Denture Conversions, TSV Multi-Unit Abutments and Components, and Low Profile Abutments and Components. The catalog carries a 2026 copyright notice for ZimVie. [5]

The BellaTek Bars and Frameworks Laboratory Manual covers interface compatibility, a design matrix, design options, standard turnaround time, ordering workflow, and key terms and conditions. It also lists ZimVie scan bodies for lab-designed bars, including part numbers for Certain 3.4 mm, 4.1 mm, 5.0 mm and 6.0 mm implants. The manual carries a 2024 copyright notice for ZimVie Inc. [6]

Applicant identity and collection context

The FDA records name ZimVie US Corp, LLC as the K260940 applicant, while the earlier K241032 BellaTek Bars clearance was submitted under Biomet 3i, LLC through a consultant. The two filings share a trade name and regulatory classification but differ in named applicant, so the K241032 record is treated as predicate documentation rather than as a ZimVie submission. [1][2][7]

The linked collection for this profile contains one 510(k) record, K260940, with one SESE decision; the record sample likewise contains that single entry. These counts describe the linked filings as of the snapshot date and are not measures of total company portfolio, sales or safety performance. No recall records are linked in the collection. [1]